Correlation Between Genmab AS and Green Hydrogen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Green Hydrogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Green Hydrogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Green Hydrogen Systems, you can compare the effects of market volatilities on Genmab AS and Green Hydrogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Green Hydrogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Green Hydrogen.

Diversification Opportunities for Genmab AS and Green Hydrogen

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Genmab and Green is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Green Hydrogen Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Green Hydrogen Systems and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Green Hydrogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Green Hydrogen Systems has no effect on the direction of Genmab AS i.e., Genmab AS and Green Hydrogen go up and down completely randomly.

Pair Corralation between Genmab AS and Green Hydrogen

Assuming the 90 days trading horizon Genmab AS is expected to under-perform the Green Hydrogen. But the stock apears to be less risky and, when comparing its historical volatility, Genmab AS is 3.76 times less risky than Green Hydrogen. The stock trades about -0.07 of its potential returns per unit of risk. The Green Hydrogen Systems is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  1,228  in Green Hydrogen Systems on September 3, 2024 and sell it today you would lose (872.00) from holding Green Hydrogen Systems or give up 71.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Green Hydrogen Systems

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Green Hydrogen Systems 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Green Hydrogen Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Genmab AS and Green Hydrogen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Green Hydrogen

The main advantage of trading using opposite Genmab AS and Green Hydrogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Green Hydrogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Green Hydrogen will offset losses from the drop in Green Hydrogen's long position.
The idea behind Genmab AS and Green Hydrogen Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets